Prostate cancer: Is inapparent tumor at endorectal MR and MR spectroscopic imaging a favorable prognostic finding in patients who select active surveillance?

Radiology

Volumn 247, Issue 2, 2008, Pages 444-450

  Cabrera, Alvin R ^a   Coakley, Fergus V ^a   Westphalen, Antonio C ^a   Lu, Ying ^a   Zhao, Shoujun ^a   Shinohara, Katsuto ^b   Carroll, Peter R ^b   Kurhanewicz, John ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER STAGING; CONTROLLED STUDY; GLEASON SCORE; HEALTH SURVEY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MORPHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROSTATE BIOPSY; PROSTATE CANCER; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; COMPUTER ASSISTED DIAGNOSIS; MIDDLE AGED; NEEDLE BIOPSY; PATHOLOGY; PREDICTION AND FORECASTING; PROSTATE TUMOR; STATISTICAL MODEL;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 44449129980     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2472070770     Document Type: Article

References (24)

1. Sakr WA, Grignon DJ. Prostate cancer: indicators of aggressiveness. Eur Urol 1997;32(suppl 3):15-23.
2. Kattan MW, Eastham JA, Wheeler TM, et al. Counseling men with prostate cancer: a nomogram for predicting the presence of small, moderately differentiated, confined tumors. J Urol 2003;170:1792-1797.
3. Wu H, Sun L, Moul JW, et al. Watchful waiting and factors predictive of secondary treatment of localized prostate cancer. J Urol 2004;171:1111-1116.
4. Liebross RH, Pollack A, Lankford SP, von Eschenbach AC, Zagars GK. Relationship of ultrasound staging and bilateral biopsy positivity to outcome in stage T1c prostate cancer treated with radiotherapy. Urology 1998;52:647-652.
5. Philip J, Dutta Roy S, Ballal M, Foster CS, Javlé P. Is a digital rectal examination necessary in the diagnosis and clinical staging of early prostate cancer? BJU Int 2005;95:969-971.
6. Nakashima J, Tanimoto A, Imai Y, et al. Endorectal MRI for prediction of tumor site, tumor size, and local extension of prostate cancer. Urology 2004;64:101-105.
7. Huch Boni RA, Boner JA, Debatin JF, et al. Optimization of prostate carcinoma staging: comparison of imaging and clinical methods. Clin Radiol 1995;50:593-600.
8. D'Amico AV, Whittington R, Malkowicz B, et al. Endorectal magnetic resonance imaging as a predictor of biochemical outcome after radical prostatectomy in men with clinically localized prostate cancer. J Urol 2000;164:759-763.
9. Males RG, Vigneron DB, Star-Lack J, et al. Clinical application of BASING and spectral/ spatial water and lipid suppression pulses for prostate cancer staging and localization by in vivo 3D 1H magnetic resonance spectroscopic imaging. Magn Reson Med 2000;43:17-22.
10. Star-Lack J, Vigneron DB, Pauly J, Kurhanewicz J, Nelson SJ. Improved solvent suppression and increased spatial excitation bandwidths for three-dimensional PRESS CSI using phase-compensating spectral/spatial spin-echo pulses. J Magn Reson Imaging 1997;7:745-757.
11. Schricker AA, Pauly JM, Kurhanewicz J, Swanson MG, Vigneron DB. Dualband spectral-spatial RF pulses for prostate MR spectroscopic imaging. Magn Reson Med 2001;46:1079-1087.
12. Prostate. In: Greene FL, Page DL, Fleming ID, et al, eds. AJCC cancer staging manual. 6th ed. New York, NY: Springer, 2002; 309-316.
13. Coakley FV, Teh HS, Qayyum A, et al. Endorectal MR imaging and MR spectroscopic imaging for locally recurrent prostate cancer after external beam radiation therapy: preliminary experience. Radiology 2004;233:441-448.
14. Jung JA, Coakley FV, Vigneron DB, et al. Prostate depiction at endorectal MR spectroscopic imaging: investigation of a standardized evaluation system. Radiology 2004;233:701-708.
15. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-174.
16. Zakian KL, Sircar K, Hricak H, et al. Correlation of proton MR spectroscopic imaging with Gleason score based on step-section pathologic analysis after radical prostatectomy. Radiology 2005;234:804-814.
17. Hardie C, Parker C, Norman A, et al. Early outcomes of active surveillance for localized prostate cancer. BJU Int 2005;95:956-960.
18. Pinover WH, Hanlon A, Lee WR, Kaplan EJ, Hanks GE. Prostate carcinoma patients upstaged by imaging and treated with irradiation: an outcome-based analysis. Cancer 1996;77:1334-1341.
19. Choo R, Klotz L, Danjoux C, et al. Feasibility study: watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progression. J Urol 2002;167:1664-1669.
20. McLaren DB, McKenzie M, Duncan G, Pickles T. Watchful waiting or watchful progression? prostate specific antigen doubling times and clinical behavior in patients with early untreated prostate carcinoma. Cancer 1998;82:342-348.
21. de Vries SH, Raaijmakers R, Kranse R, Blijenberg BG, Schroder FH. Prostate cancer characteristics and prostate specific antigen changes in screening detected patients initially treated with a watchful waiting policy. J Urol 2004;172:2193-2196.
22. Choo R, Do V, Sugar L, et al. Comparison of histologic grade between initial and follow-up biopsy in untreated, low to intermediate grade, localized prostate cancer. Can J Urol 2004;11:2118-2124.
23. Hruby G, Choo R, Klotz L, et al. The role of serial transrectal ultrasonography in a 'watchful waiting' protocol for men with localized prostate cancer. BJU Int 2001;87:643-647.
24. Coakley FV, Chen I, Qayyum A, et al. Validity of prostate-specific antigen as a tumour marker in men with prostate cancer managed by watchful-waiting: correlation with findings at serial endorectal magnetic resonance imaging and spectroscopic imaging. BJU Int 2007;99:41-45.